Alkem Laboratories Limited

NSEI:ALKEM Rapporto sulle azioni

Cap. di mercato: ₹739.5b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Alkem Laboratories Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Vikas Gupta

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOless than a year
Proprietà del CEOn/a
Durata media del managementless than a year
Durata media del Consiglio di amministrazione9.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You

Sep 24
What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 03
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 13
Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Jul 13
Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Jun 13
Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Jun 01
Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

May 22
Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Feb 13
Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

Jan 17
Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Dec 27
We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 14
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Aug 02
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Jul 07
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

May 22
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Mar 27
We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Dec 26
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Jul 27
Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 13
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Jun 11
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

May 23
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Mar 06
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Feb 21
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Feb 08
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?

Jan 09
Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Nov 30
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

AMMINISTRATORE DELEGATO

Vikas Gupta

less than a year

Mandato

Dr. Vikas Gupta is Chief Executive Officer of Alkem Laboratories Limited from September 22, 2023. He has experience in Pharmaceutical Sector and brings with him deep experience across therapeutic areas inc...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Basudeo Singh
Executive Chairman51.1yrs₹200.60m13.31%
₹ 98.4b
Sarvesh Singh
VP of Sales & Marketing and Executive Directorno data₹44.50m0%
₹ 0
Sandeep Singh
MD & Executive Directorless than a year₹81.50m0.0065%
₹ 48.3m
Mritunjay Singh
Executive Directorno data₹104.30m8.58%
₹ 63.5b
Srinivas Singh
Executive Director2yrs₹96.60m0.086%
₹ 635.1m
Madhurima Singh
Executive Directorno data₹104.10m8.77%
₹ 64.9b
Vikas Gupta
Chief Executive Officerless than a yearNessun datoNessun dato
Akhilesh Sharma
President & Chief Medical Officerno dataNessun datoNessun dato
Kaustav Banerjee
President & Head Medtech Businessless than a yearNessun datoNessun dato
Rajorshi Ganguli
President & Global HR Headno dataNessun datoNessun dato
Nitin Agrawal
CFO & President of Financeless than a yearNessun datoNessun dato
Satish Singh
Head of Operationsno dataNessun dato0.060%
₹ 444.9m

1.0yrs

Durata media

55yo

Età media

Gestione esperta: Il team dirigenziale di ALKEM non è considerato esperto (durata media 0.9 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Basudeo Singh
Executive Chairman51.1yrs₹200.60m13.31%
₹ 98.4b
Sarvesh Singh
VP of Sales & Marketing and Executive Director4.8yrs₹44.50m0%
₹ 0
Sandeep Singh
MD & Executive Director11.1yrs₹81.50m0.0065%
₹ 48.3m
Mritunjay Singh
Executive Director15.8yrs₹104.30m8.58%
₹ 63.5b
Srinivas Singh
Executive Director2yrs₹96.60m0.086%
₹ 635.1m
Madhurima Singh
Executive Director2.8yrs₹104.10m8.77%
₹ 64.9b
Arun Purwar
Independent Director9.5yrs₹3.30mNessun dato
Sudha Ravi
Independent Director9.3yrs₹3.10mNessun dato
Sangeeta Singh
Independent Director9.3yrs₹3.00mNessun dato
Narendra Aneja
Independent Director4.5yrs₹3.20mNessun dato
Sujjain Talwar
Independent Director2.1yrs₹2.70mNessun dato

9.3yrs

Durata media

61yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ALKEM sono considerati esperti (durata media dell'incarico 9.2 anni).